161 related articles for article (PubMed ID: 15107999)
1. HMGI(Y) gene expression as a potential marker of thyroid follicular carcinoma.
Czyz W; Balcerczak E; Jakubiak M; Pasieka Z; Kuzdak K; Mirowski M
Langenbecks Arch Surg; 2004 Jun; 389(3):193-7. PubMed ID: 15107999
[TBL] [Abstract][Full Text] [Related]
2. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the HMGI(Y) gene in a microfollicular adenoma of the thyroid.
Dal Cin P; Fusco A; Belge G; Chiappetta G; Fedele M; Pauwels P; Bullerdiek J; Van den Berghe H
Genes Chromosomes Cancer; 1999 Mar; 24(3):286-9. PubMed ID: 10451711
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
[TBL] [Abstract][Full Text] [Related]
5. PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues.
Lacroix L; Mian C; Barrier T; Talbot M; Caillou B; Schlumberger M; Bidart JM
Eur J Endocrinol; 2004 Sep; 151(3):367-74. PubMed ID: 15362967
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
[TBL] [Abstract][Full Text] [Related]
7. HMGI(Y) gene expression in colorectal cancer: comparison with some histological typing, grading, and clinical staging.
Balcerczak M; Pasz-Walczak G; Balcerczak E; Wojtylak M; Kordek R; Mirowski M
Pathol Res Pract; 2003; 199(10):641-6. PubMed ID: 14666966
[TBL] [Abstract][Full Text] [Related]
8. Classification of follicular thyroid tumors by molecular signature: results of gene profiling.
Barden CB; Shister KW; Zhu B; Guiter G; Greenblatt DY; Zeiger MA; Fahey TJ
Clin Cancer Res; 2003 May; 9(5):1792-800. PubMed ID: 12738736
[TBL] [Abstract][Full Text] [Related]
9. [Loss of heterozygosity on chromosome 3p in thyroid tumors].
Hu MJ; Xu HD; Zhou R; Li XF; Zhang HY
Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):305-8. PubMed ID: 18956647
[TBL] [Abstract][Full Text] [Related]
10. The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias.
Chiappetta G; Bandiera A; Berlingieri MT; Visconti R; Manfioletti G; Battista S; Martinez-Tello FJ; Santoro M; Giancotti V; Fusco A
Oncogene; 1995 Apr; 10(7):1307-14. PubMed ID: 7731681
[TBL] [Abstract][Full Text] [Related]
11. The natural protein kinase C alpha mutant is present in human thyroid neoplasms.
Prévostel C; Alvaro V; de Boisvilliers F; Martin A; Jaffiol C; Joubert D
Oncogene; 1995 Aug; 11(4):669-74. PubMed ID: 7651730
[TBL] [Abstract][Full Text] [Related]
12. Expression of HMGI(Y) associated with malignant phenotype of human gastric tissue.
Nam ES; Kim DH; Cho SJ; Chae SW; Kim HY; Kim SM; Han JJ; Shin HS; Park YE
Histopathology; 2003 May; 42(5):466-71. PubMed ID: 12713623
[TBL] [Abstract][Full Text] [Related]
13. The associations between RAS mutations and clinical characteristics in follicular thyroid tumors: new insights from a single center and a large patient cohort.
Fukahori M; Yoshida A; Hayashi H; Yoshihara M; Matsukuma S; Sakuma Y; Koizume S; Okamoto N; Kondo T; Masuda M; Miyagi Y
Thyroid; 2012 Jul; 22(7):683-9. PubMed ID: 22650231
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in normal and malignant thyroid tissues by real-time polymerase chain reaction.
Egawa C; Miyoshi Y; Iwao K; Shiba E; Noguchi S
Oncology; 2001; 61(4):293-8. PubMed ID: 11721176
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic significance of high mobility group I(Y) protein expression in intraductal papillary mucinous tumors of the pancreas.
Abe N; Watanabe T; Izumisato Y; Masaki T; Mori T; Sugiyama M; Chiappetta G; Fusco A; Fujioka Y; Atomi Y
Pancreas; 2002 Aug; 25(2):198-204. PubMed ID: 12142746
[TBL] [Abstract][Full Text] [Related]
17. Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.
Lazar V; Bidart JM; Caillou B; Mahé C; Lacroix L; Filetti S; Schlumberger M
J Clin Endocrinol Metab; 1999 Sep; 84(9):3228-34. PubMed ID: 10487692
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias.
Belge G; Meyer A; Klemke M; Burchardt K; Stern C; Wosniok W; Loeschke S; Bullerdiek J
Genes Chromosomes Cancer; 2008 Jan; 47(1):56-63. PubMed ID: 17943974
[TBL] [Abstract][Full Text] [Related]
19. HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias.
Chiappetta G; Ferraro A; Vuttariello E; Monaco M; Galdiero F; De Simone V; Califano D; Pallante P; Botti G; Pezzullo L; Pierantoni GM; Santoro M; Fusco A
Eur J Cancer; 2008 May; 44(7):1015-21. PubMed ID: 18375116
[TBL] [Abstract][Full Text] [Related]
20. High mobility group HMGI(Y) protein expression in head and neck squamous cell carcinoma.
Rho YS; Lim YC; Park IS; Kim JH; Ahn HY; Cho SJ; Shin HS
Acta Otolaryngol; 2007 Jan; 127(1):76-81. PubMed ID: 17364334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
